Desensitization to etoposide. A case report;Desensibilización para etopósido. Comunicación de un caso

Revista Alergia Mexico

Volumn 57, Issue 1, 2010, Pages 33-36

  Álvarez Cardona, Aristóteles ^d   Hernández Nieto, Leticia ^d   Pérez Gómez, Martín ^a   Pedroza Meléndez, Álvaro ^b   Huerta López, José G ^c  

^a Servicio de Oncología Médica   (Mexico)

^b Servicio de Alergia   (Mexico)

^c INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^d NONE

Author keywords

Desensitization; Drug hypersensitivity; Etoposide

Indexed keywords

ANTIHISTAMINIC AGENT; ASPARAGINASE; ETOPOSIDE; STEROID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANGIONEUROTIC EDEMA; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CHILD; DESENSITIZATION; DRUG HYPERSENSITIVITY; HUMAN; HYPOTENSION; MALE; SCHOOL CHILD; URTICARIA;

EID: 77953430356     PISSN: 00025151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Weiss RB, Bruno S. Hypersensitivity reactions to cancer chemotherapeutic agents. Ann Intern Med 1981;94:66-72.
2. Vervolet D, Durham S. Adverse reactions to drugs. BMJ 1998;316:1511-1514.
3. Zweizig S, Roman LD, Muderspach LI. Death from anaphylaxis to cisplatin: a case report. Gynecol Oncol 1994;53:121-122.
4. Weiss RB. Hypersensitivity reactions. Semin Oncol 1992;19:458-477.
5. Shepherd GM. Hypersensitivity reactions to chemotherapeutic drugs. Clin Rev Allergy Immunol 2003;24:253-262.
6. Lee C, Gianos M, Klaustermeyer WB. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents. Ann Allergy Asthma Immunol 2009;102(3):179-187.
7. Wendel G, Stark B, Jamison RB, et al. Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med 1985;312:1229-1332.
8. Castells M. Drug desensitization in oncology: Chemotherapy agents and monoclonal antibodies. In Pichler WJ editor. Drug hypersensitivity. Basel Karger 2007;413-425.
9. Markman M, Kennedy A, Webster K, et al. An effective and more conveniente drug drug regimen for prophylaxis aganinst paclitaxel-associated hypersensitivity reactions. J Cancer Res Clin Oncol 1999;125:427-429.
10. Markman M, Kennedy A, Webster K, et al. Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center. J Clin Oncol 2000;18:102-105.
11. Markman M, Hsieh F, Zannoti K, et al. Initial experience with novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin hypersensitivity reactions. J Cancer Resp Clin Oncol 2004;130:25-28.
12. Sweet AU, Stieber DA. Successful etoposide desensitization protocol in autologous stem cell transplant. J Oncol Pharm Practice 2001;7:55-56.
13. Kellie SJ, Crist WM, Pui CH, et al. Hypersensitivity reactions to epidophyllotoxins in children with acute lymphoblastic leucemia. Cancer 1991;67:1070-1075.
14. Carstensen H, Nolte H, Hertz H, et al. Hypersensitivity reactions to teniposide in children. J Clin Oncol 1987;5:1491-1492.
15. Nolte H, Carstensen H, Hertz H. VM-26 (teniposide)-induced hypersensitivity and degranulation of basophils in children. Am J Pediatr Hematol Oncol 1998;10:308.
16. Hudson MM, Weinstein HJ, Donaldson SS, et al. Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease. J Clin Oncol 1993;11:1080-1084.
17. Siderov J, Prasad P, De Boer R, et al. Safe administration of etoposide phosphate alter hypersensitivity reaction to intravenous etoposide. Br J Cancer 2002;86:12-13.
18. Hartmann JT, Lipp HP. Camptothecin and podophyllotoxin derivatives. Drug Safety 2006;29:209-230.
19. Soyer OU, Aytac S, Tnucer A, et al. Alternative algorithm fo L-asparaginase allergy in children with acute lymphoblastic leukemia. J Allergy Clin Immunol 2009;123(4):895-899.